Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study
Clinical trial NCT04266197 · COMPLETED
Trial details
- NCT number
- NCT04266197
- Sponsor
- Respira Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2024-11-20
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.